Variant report
Variant | esv4689 |
---|---|
Chromosome Location | chr5:177875087-177875566 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:6)
- CpG islands (count:122)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:6 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ELF1 | chr5:177875533-177875840 | K562 | blood: | n/a | n/a |
2 | EP300 | chr5:177875430-177877493 | SK-N-SH | brain: | n/a | chr5:177875954-177875968 |
3 | NR3C1 | chr5:177875021-177875635 | A549 | lung: | n/a | n/a |
4 | PAX5 | chr5:177875017-177875526 | GM12878 | blood: | n/a | n/a |
5 | REST | chr5:177875131-177875456 | PANC-1 | pancreas: | n/a | n/a |
6 | SIX5 | chr5:177875082-177875485 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:177875140-177875190 | PrEC | prostate: | n/a |
2 | chr5:177875440-177875490 | HCF | heart: | n/a |
3 | chr5:177875440-177875490 | SK-N-SH | brain: | n/a |
4 | chr5:177875440-177875490 | HIPEpiC | eye: | n/a |
5 | chr5:177875440-177875490 | PFSK-1 | brain: | n/a |
6 | chr5:177875440-177875490 | AG09309 | skin: | n/a |
7 | chr5:177875440-177875490 | K562 | blood: | n/a |
8 | chr5:177875440-177875490 | CMK | blood: | n/a |
9 | chr5:177875440-177875490 | HUVEC | blood vessel: | n/a |
10 | chr5:177875140-177875190 | HPAEpiC | pulmonary alveolar: | n/a |
11 | chr5:177875440-177875490 | NHDF-neo | bronchial: | n/a |
12 | chr5:177875140-177875190 | SK-N-MC | brain: | n/a |
13 | chr5:177875140-177875190 | HNPCEpiC | eye: | n/a |
14 | chr5:177875440-177875490 | HNPCEpiC | eye: | n/a |
15 | chr5:177875440-177875490 | HEK293 | kidney: | embryo |
16 | chr5:177875140-177875190 | ProgFib | skin: | n/a |
17 | chr5:177875140-177875190 | HCT-116 | colon: | n/a |
18 | chr5:177875440-177875490 | U87 | brain: | n/a |
19 | chr5:177875440-177875490 | HCT-116 | colon: | n/a |
20 | chr5:177875140-177875190 | PFSK-1 | brain: | n/a |
21 | chr5:177875440-177875490 | Caco-2 | colon: | n/a |
22 | chr5:177875140-177875190 | GM12891 | blood: | n/a |
23 | chr5:177875440-177875490 | Hela-S3 | cervix: | n/a |
24 | chr5:177875440-177875490 | AG04449 | skin: | fetal |
25 | chr5:177875440-177875490 | RPTEC | kidney: | n/a |
26 | chr5:177875140-177875190 | GM19239 | blood: | n/a |
27 | chr5:177875440-177875490 | HRPEpiC | eye: | n/a |
28 | chr5:177875140-177875190 | GM12878 | blood: | n/a |
29 | chr5:177875140-177875190 | H1-hESC | embryonic stem cell: | embryo |
30 | chr5:177875440-177875490 | MCF10A-Er-Src | breast: | n/a |
31 | chr5:177875440-177875490 | ovcar-3 | ovarian: | n/a |
32 | chr5:177875140-177875190 | HL-60 | blood: | n/a |
33 | chr5:177875140-177875190 | NT2-D1 | testis: | n/a |
34 | chr5:177875440-177875490 | Jurkat | blood: | n/a |
35 | chr5:177875440-177875490 | SAEC | small airway: | n/a |
36 | chr5:177875140-177875190 | HEK293 | kidney: | embryo |
37 | chr5:177875140-177875190 | AG04450 | lung: | fetal |
38 | chr5:177875140-177875190 | U87 | brain: | n/a |
39 | chr5:177875140-177875190 | A549 | lung: | n/a |
40 | chr5:177875440-177875490 | BE2_C | brain: | n/a |
41 | chr5:177875440-177875490 | HRE | kidney: | n/a |
42 | chr5:177875140-177875190 | HUVEC | blood vessel: | n/a |
43 | chr5:177875140-177875190 | AG04449 | skin: | fetal |
44 | chr5:177875440-177875490 | AG04450 | lung: | fetal |
45 | chr5:177875440-177875490 | SKMC | muscle: | n/a |
46 | chr5:177875140-177875190 | RPTEC | kidney: | n/a |
47 | chr5:177875140-177875190 | SK-N-SH | brain: | n/a |
48 | chr5:177875440-177875490 | ECC-1 | luminal epithelium: | n/a |
49 | chr5:177875140-177875190 | T-47D | breast: | n/a |
50 | chr5:177875140-177875190 | NH-A | brain: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:177873433..177876156-chr5:177880110..177882555,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000245688 | TF binding region |
ENSG00000245688 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559158822 | chr5:177875089-177875090 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs532937156 | chr5:177875094-177875095 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs185545176 | chr5:177875111-177875112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564568473 | chr5:177875117-177875118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112235660 | chr5:177875121-177875122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375218079 | chr5:177875147-177875148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113268776 | chr5:177875151-177875152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs56410177 | chr5:177875179-177875180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113538687 | chr5:177875181-177875182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs55652110 | chr5:177875200-177875201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112600919 | chr5:177875211-177875212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11958324 | chr5:177875241-177875242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11958330 | chr5:177875271-177875272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10063547 | chr5:177875291-177875292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112197790 | chr5:177875298-177875299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113886736 | chr5:177875301-177875302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111963727 | chr5:177875331-177875332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112634239 | chr5:177875361-177875362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs111406003 | chr5:177875391-177875392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529654071 | chr5:177875411-177875412 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548093137 | chr5:177875416-177875417 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs58754033 | chr5:177875418-177875419 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs112890345 | chr5:177875421-177875422 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143987829 | chr5:177875431-177875432 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144915146 | chr5:177875440-177875441 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190257564 | chr5:177875441-177875442 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569688067 | chr5:177875443-177875444 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11956256 | chr5:177875446-177875447 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs111755587 | chr5:177875451-177875452 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143160317 | chr5:177875474-177875475 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534371360 | chr5:177875478-177875479 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573288897 | chr5:177875489-177875490 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575843762 | chr5:177875515-177875516 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182702411 | chr5:177875526-177875527 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs116122700 | chr5:177875530-177875531 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545146041 | chr5:177875545-177875546 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11956284 | chr5:177875552-177875553 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs187646440 | chr5:177875558-177875559 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:177856800-177887200 | Weak transcription | Right Atrium | heart |
2 | chr5:177866600-177876200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr5:177869400-177876200 | Weak transcription | Brain Angular Gyrus | brain |
4 | chr5:177871200-177875600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
5 | chr5:177871800-177880600 | Weak transcription | Fetal Thymus | thymus |
6 | chr5:177874600-177875400 | Enhancers | K562 | blood |
7 | chr5:177874600-177888200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr5:177874800-177876200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr5:177875400-177875800 | Flanking Active TSS | K562 | blood |